Eligibility for and prescription of urate-lowering treatment in patients with incident gout in England

Kuo, Chang-Fu and Grainge, Matthew J. and Mallen, Christian and Zhang, Weiya and Doherty, Michael (2014) Eligibility for and prescription of urate-lowering treatment in patients with incident gout in England. Journal of the American Medical Association, 312 (24). pp. 2684-2686. ISSN 0098-7484

[img] PDF - Repository staff only - Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
Download (370kB)

Abstract

Gout is caused by urate crystal deposition secondary to persistent hyperuricemia. Current guidelines recommend urate-lowering treatment to prevent crystal deposition and encourage crystal dissolution for patients with more severe gout or concomitant conditions.1,2 However, after the first diagnosis, it remains unclear when such treatment is appropriate. We investigated the timing of eligibility for and prescription of urate-lowering treatment following first gout diagnosis and factors associated with prescription.

Item Type: Article
Schools/Departments: University of Nottingham UK Campus > Faculty of Medicine and Health Sciences > School of Medicine > Division of Epidemiology and Public Health
University of Nottingham UK Campus > Faculty of Medicine and Health Sciences > School of Medicine > Division of Rheumatology, Orthopaedics and Dermatology
Identification Number: https://doi.org/10.1001/jama.2014.14484
Depositing User: Claringburn, Tara
Date Deposited: 18 Aug 2016 15:14
Last Modified: 17 Sep 2016 18:22
URI: http://eprints.nottingham.ac.uk/id/eprint/35899

Actions (Archive Staff Only)

Edit View Edit View